focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Trackwise Designs wins deal; Cake Box names CFO

Fri, 21st Oct 2022 21:29

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

ThinkSmart Ltd - Perth, Australia-based digital payments platform - Says the Federal Court of Australia approved orders for the company to convene a meeting of shareholders to vote on its acquisition by Tuscan Equity Pty Ltd. Expects the scheme meeting to take place through a computershare virtual meeting platform on November 16.

----------

Trackwise Designs PLC - Tewkesbury, Gloucestershire-based products using printed circuit technology - Enters a new agreement for a fixed quantity of flexible printed circuit boards which are due to be delivered through to July 2023 to its unnamed UK EV OEM customer. The new commercial order provides for a GBP4.0 million advanced payment in 2022.

----------

Cake Box Holdings PLC - Wembley, London-based egg-free cream cake seller - Appoints Michael Botha as chief financial officer. He has worked in senior finance and commercial role for the last 20 years.

----------

Globalworth Real Estate Investments Ltd - Investor in real estate in Central and Eastern Europe, with particular focus on Poland and Romania - Says Chief Executive Officer Dimitris Raptis has decided to step down as of December 31. Notes that he will continue to support Globalworth in an advisory role allowing time for a handover period. He joined in 2013 as deputy CEO & Chief Investment Officer and became CEO in 2020.

----------

Corero Network Securities PLC - Amersham, Buckinghamshire-based distributed denial of service cyber defence solutions - Expands its distributed denial of service protection partnership with Juniper Networks, across Juniper's PTX and MX series routers. The extensions prevent DDoS attack traffic and include new enhanced protections against DDoS "carpet bombing".

----------

Trident Royalties PLC - London-based mining royalty and streaming company - Notes Equinox Gold's updated feasibility study for its Los Filos mine complex in Mexico. Explains that the feasibility study contemplates the construction of a carbon-in-leach processing plant beginning in the half of 2023. It outlines peak gold production averaging 360,000 ounces per year to 2030 from 2025, including production in excess of 400,000 ounces in 2025. By comparison, Equinox's latest guidance for 2022 production at Los Filos is 155,000 to 170,000 ounces. Holds an offtake agreement for 50% of all refined gold production up to a cap of 1.1 million ounces from Los Filos. "Equinox continues to deliver on its growth plans with the release of this updated feasibility study, which highlights the tremendous potential at Los Filos. The potential expansion at Los Filos underscores the organic growth within Trident's gold offtakes portfolio," CEO Adam Davidson comments.

----------

Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company focused on hormonal diseases - Says the required majorities of scheme shareholders voted to approve its acquisition by Neurocrine at a court meeting and general meeting.

----------

Secure Property Development & Investment PLC - London-headquartered commercial property investor focused on southeastern Europe - Chief Executive Officer Lambros Anagnostopoulos buys 1.9 million shares at GBP0.0575 each.

----------

IOG PLC - North Sea-focused gas and infrastructure operator - Chief Executive Officer Rupert Newall purchases 600,000 shares at 9.31 pence per ordinary share.

----------

By Abby Amoakuh; abbyamoakuh@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
10 Jan 2019 11:33

Diurnal Shares Surge As Secures Second Patent For Chronocort In US

LONDON (Alliance News) - Diurnal Group PLC on Thursday said the US Patent & Trademark Office has granted the company a second US patent for Chronocort.Diurnal shares almost tripled on a

Read more
10 Jan 2019 11:26

Diurnal awarded US patent for Chronocort product

(Sharecast News) - Specialty pharmaceutical company Diurnal Group announced on Thursday that the US Patent and Trademark Office (USPTO) has granted a second US patent for its 'Chronocort' modified release hydrocortisone product.

Read more
17 Oct 2018 12:10

Diurnal halts US development of Chronocort after European trials come up short

(Sharecast News) - Speciality pharmaceutical company Diurnal has put all development activities for its modified release hydrocortisone product on hold after it failed to meet its primary endpoint in a recent phase-three European trial.

Read more
17 Oct 2018 10:41

Diurnal Puts All Chronocort US Development Activities On Hold

LONDON (Alliance News) - Diurnal Group PLC said Wednesday it decided to put all US development activities for its Chronocort product on hold, after it failed to meet its primary objective in its a

Read more
8 Oct 2018 17:07

LONDON MARKET CLOSE: Stocks End Lower On Chinese And Italian Woes

LONDON (Alliance News) - Stocks closed lower Monday on the actions of the Chinese and Italian governments, as the pound continued its fall on news from 10 Downing Street there remains "big in of

Read more
8 Oct 2018 15:15

Diurnal Group Child Adrenal Insufficiency Drug Approved In Scotland

LONDON (Alliance News) - Diurnal Group PLC said Monday the Scottish Medicines Consortium approved the routine use of Alkindi, a first-line treatment of young children with adrenal insufficiency to

Read more
8 Oct 2018 12:00

LONDON MARKET MIDDAY: China Prompts Sell-Off In Europe; Insurers Fall

LONDON (Alliance News) - Share prices in London had slipped firmly into the red by midday on Monday following a slump in Chinese equities overnight."Europe is following the Asian lead, with a 3%

Read more
8 Oct 2018 10:33

WINNERS & LOSERS SUMMARY: French Connection In Vogue On Possible Sale

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - up 1.0%. The asset manager confirmed it is in to

Read more
8 Oct 2018 09:29

Diurnal's endocrine drug does not meet trial objective

(Sharecast News) - Clinical trials of Diurnal Group's Chronocort drug failed to meet the primary objective of proving superior to conventional therapy in endocrine control over a 24-hour period.

Read more
8 Oct 2018 08:54

Shares In IP Group, Diurnal Suffer After Chronocort Trial Disappoints

LONDON (Alliance News) - Diurnal Group PLC said Monday its phase-three European trial of Chronocort did not meet its primary objective, causing shares in the pharmaceutical company to property IP

Read more
8 Oct 2018 07:48

LONDON MARKET PRE-OPEN: Lower Call; Schroders Confirms Lloyds Talks

LONDON (Alliance News) - Stocks in London on Monday are set to continue last week's slide, fuelled by concerns that strong US economic data will lead to a quickened pace of interest rate hikes.In

Read more
5 Oct 2018 09:20

Diurnal kicks off adrenal condition trial with first patients

(Sharecast News) - Specialist pharmaceutical company Diurnal said it had enrolled the first two patients in its US-based Chronocort phase III trial for adults with congenital adrenal hyperplasia (CAH).

Read more
5 Oct 2018 08:16

Diurnal Enrols First Patients In Phase Three US Chronocort Trial

LONDON (Alliance News) - Pharmaceutical company Diurnal Group PLC on Friday said the first two patients have been enrolled into its phase three US trial of Chronocort.Chronocort is a form a

Read more
20 Sep 2018 09:56

Diurnal Generates First Revenue But Loss Deepens As Costs Rise

LONDON (Alliance News) - Pharmaceutical firm Diurnal Group PLC said Thursday its annual loss deepened amid higher costs despite generating its first revenue from drug sales.For the year the

Read more
15 Aug 2018 12:39

German Body Says Diurnal Alkindi's Benefit Over Generic Not Proven

LONDON (Alliance News) - Diurnal Group PLC said Wednesday a German body published a study which says that the benefit of the company's product Alkindi over generic hydrocortisone has not been

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.